{"id":"W2559773245","doi":"10.18553/jmcp.2016.16233","title":"Duration of Treatment in Prostate Cancer Patients Treated with Abiraterone Acetate or Enzalutamide","year":2016,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"Genentech; Astellas Pharma; Janssen Scientific Affairs; Regeneron Pharmaceuticals; Novo Nordisk; Sanofi; GlaxoSmithKline; Pfizer; Allergan; Bristol-Myers Squibb","keywords":"Abiraterone acetate; Enzalutamide; Medicine; Prostate cancer; Hazard ratio; Internal medicine; Proportional hazards model; Oncology; Docetaxel; Cancer; Urology; Gynecology; Androgen deprivation therapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000153492,0.0002208334,0.0005274212,0.0002993415,0.0000465538,0.00001754723,0.00009648762,0.00002765975,0.000299214],"category_scores_gemma":[0.00002726164,0.00009992637,0.0001076263,0.00034318,0.00009059803,0.0002576331,0.0000204185,0.0001415938,0.000005840936],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001693093,"about_ca_system_score_gemma":0.0006012924,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002941382,"about_ca_topic_score_gemma":0.0007591867,"domain_scores_codex":[0.9982659,0.000116085,0.0006382957,0.0001962607,0.0004743518,0.0003090971],"domain_scores_gemma":[0.9985359,0.00005295088,0.000490108,0.000143717,0.0006024947,0.0001747943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03551045,0.0007468305,0.7800178,0.0002499681,0.0005930245,0.001068575,0.002515835,0.00002558107,0.02238879,0.000002916846,0.0004112573,0.156469],"study_design_scores_gemma":[0.1007857,0.01000951,0.5502481,0.002001527,0.0008815023,0.00007179326,0.0009225705,0.00001224546,0.3190007,0.00001629971,0.01570859,0.000341442],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964159,0.0009422848,0.000003155977,0.001014381,0.0001305292,0.0009448289,0.00006507203,0.000009052442,0.0004747803],"genre_scores_gemma":[0.9878292,0.009232875,0.00007259905,0.00004670687,0.0002459629,0.00004327221,0.00001490212,0.00003153852,0.002482951],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2966119,"threshold_uncertainty_score":0.4427379,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03042328370747812,"score_gpt":0.3432578116156167,"score_spread":0.3128345279081386,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}